In December 2023, through the development efforts of CRISPR Therapeutics and Vertex Pharmaceuticals, their decades-long ...

The high cost of sickle cell gene therapies is pushing private insurers and Medicaid programs to develop new payment models.

The Philadelphia Citizen is recognizing CHOP doctors Alexis Thompson and Dr. Stephan Grupp with the 'Disruptors of the Year' ...

Nearly a year after new sickle cell gene therapies were approved, CNBC's Bertha Coombs reports a small number of patients are starting to complete the months-long course of treatments, but the ...

The Philadelphia Citizen is recognizing CHOP doctors Alexis Thompson and Dr. Stephan Grupp with the Disruptors of the year ...

The Medical University of South Carolina Health has established the Rena N. Grant Sickle Cell Center to help treat those ...

A SYSTEMATIC review by the American Society of Hematology (ASH) has found no evidence to support sickle cell trait (SCT) as a cause of acute pain crises or sudden exertion-related death. This finding ...

The Medical University of South Carolina is expanding its access to state-supported Sickle Cell programs for “warriors,” or ...

But deaths have only continued to mount. At least five were recorded in 2024, including a New York City recruit who died of heatstroke, a Kentucky man who exerted himself during water-based survival ...

Scott Turner Department of Housing and Urban Development secretary, announced a new Department of Government Efficiency Task ...

Deshawn "DJ" Chow is one of just over 100 sickle cell patients who have undergone treatment with new gene therapies. CVS Health CEO David Joyner said private insurers and employer-sponsored health ...

MUSC recieved updatesThe MUSC Board of Trustees received a key program update at the February board meeting on a ...